×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS24 Utilization of “Pharmaceuticals for Specific Use” for Pediatric Drug Development
Session Chair(s)
Kayoko Kikuchi, PhD
Development Office for Translational Research
Fujita Health University, Japan
Speaker(s)
Atsushi Noguchi, MS
Atsushi Noguchi, MS
Pharmaceuticals and Medical Devices Agency, Japan
Reviewer, Office of New Drug V
Keiji Wada, PhD, MBA
Keiji Wada, PhD, MBA
Eli Lilly Japan K.K., Japan
Manager
Kazumoto Iijima, MD, PhD
Kazumoto Iijima, MD, PhD
Kobe University Graduate School of Medicine, Japan
Professor and Chairman, Department of Pediatrics
Have an account?